44. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen detected and symptomatic early stage breast cancer cases

Abstract

Background: It is based on high evidence randomized controlled trials that mammography screening is able to reduce breast cancer mortality up to 32%. Some recent studies doubt the impact of the non-palpable early stage breast cancer detection on mortality reduction. The aim of this study was to analyze the clinicopathological and long term follow up data of breast cancer patients diagnosed via population based mammographic screening in comparison to a non-screened symptomatic group of early staged breast cancer patients.